1. Beierwaltes W.H. Update on basic research and clinical experience with metaiodobenzylguanidine. Med. Pediat. Oncol. 15: 163, 1987.
2. Nakajo M., Shapiro B, Sisson J.C., Swanson D.P., Beierwaltes W.H. Salivary gland accumulation of meta-l-131-iodobenzylguanidine. J. Nucl. Med. 25: 2, 1984.
3. Nakajo M., Shapiro B, Copp J., Kalff V., Gross M.D., Sisson J.C., Beierwaltes W.H. The normal and abnormal distribution of the adrenomedullary imaging agent l-131-iodobenzylguanidine (l-131 MIBG) in man; evaluation of scintigraphy. J. Nucl. Med. 24: 672, 1983.
4. Sisson J., Wieland D. Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. Am. J. Physiol. Imaging 1: 96, 1986.
5. Hanson M.W., Feldman J.M., Beam C.A., Leight G.S., Coleman R.E. Iodine-131-labeled metaiodobenzylguanidine scintigraphy and biochemical analysis in suspected pheochromocytoma. Arch. Intern. Med. 151: 1397, 1991.